Theraclion: Total Number of Shares and Voting Rights as of July 31, 2026

Theraclion, a medical technology company, has announced its total number of shares and voting rights as of July 31, 2026. Listed on Euronext Growth Paris, the company is eligible for the French PEA-PME investment scheme and has the ISIN code FR0010120402. According to the press release, Theraclion's share capital consists of 73,543,457 shares. The theoretical total number of voting rights is 88,767,504, while the actual number is 86,957,843.

Actual voting rights are those that can be exercised at general meetings, after deducting shares deprived of voting rights. This regular publication is a legal requirement of the French Financial Markets Authority.